114 results
8-K
EX-99.1
JAZZ
Jazz Pharmaceuticals plc
9 Aug 23
Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance
4:07pm
by means of greater safety because Xywav provides a greatly reduced chronic sodium burden compared to Xyrem." Further, FDA stated that "the differences
8-K
EX-99.1
22f j1hes
10 May 23
Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance
4:08pm
8-K
EX-99.1
r8hs8kuca21
3 Aug 22
Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance
4:07pm
8-K
EX-99.1
s80 7i6splj
4 May 22
Jazz Pharmaceuticals Announces First Quarter 2022
4:13pm
8-K
EX-99.1
x9xopdik2fj8m6v91c
1 Mar 22
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2021
4:07pm
8-K
EX-99.1
3t8tkeb7
9 Nov 21
Jazz Pharmaceuticals Announces Third Quarter 2021
4:07pm
8-K
EX-99.1
zk3cyth hxo
3 Aug 21
Jazz Pharmaceuticals Announces Second Quarter 2021
4:07pm